Drugmakers to raise US prices on over 250 medicines starting Jan. 1
The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.
Sangamo Therapeutics: Left At The Alter (Rating Downgrade)
Sangamo Therapeutics faces challenges as Pfizer terminates partnership for hemophilia A gene therapy, impacting share price ...
3 Reasons to Buy Pfizer Stock Like There's No Tomorrow
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec ...
Penn’s royalties from Pfizer-BioNTech COVID-19 vaccine grow to at least $2 billion after new settlement
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact
Sangamo Therapeutics shares lost more than half their value when Pfizer pulled out of a collaboration agreement.
STAT6h
Pfizer kills hemophilia gene therapy deal, imperiling Sangamo
Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.
Providing context to claims that the judge overseeing Mangione’s case is married to former Pfizer executive
A judge who is married to a former Pfizer executive is overseeing Mangione’s federal pretrial hearings. But she won’t oversee ...
2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
Morningstar11h
Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends hemophilia pact
It has been since 2008. Sangamo Therapeutics Inc.'s stock tumbled 56% on Tuesday for its second-biggest one-day percentage decline ever, after Pfizer Inc. terminated a hemophilia A gene-therapy ...
Drugmakers to raise prices of over 250 medicines starting Jan. 1
Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol ...
Pharmaceutical Technology on MSN13h
Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership
Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.